Frontiers in Pharmacology

Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study

Cancers

HER2-positive metastatic breast cancer: Available treatments and current developments

BMC Medicine

Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: Evidence from the ESME real-world database

Frontiers in Pharmacology

The role of irreversible pan-HER tyrosine kinase inhibitors in the treatment of HER2-positive metastatic breast cancer

Clinical Cancer Research

Phase I study and cell-free DNA analysis of T-DM1 and metronomic temozolomide for secondary prevention of HER2-positive breast cancer brain metastases 

OncLive

ARX788 meets PFS end point in HER2+ metastatic breast cancer

Translational Cancer Research

Pyrotinib for HER2-positive metastatic breast cancer: a systematic review and meta-analysis

Acta Oncologica

A nationwide observational study in heavily pretreated metastatic HER2-positive breast cancer patients

Breast Cancer Research and Treatment

Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer

Breast Cancer

Clinical outcome of patients with isolated central nervous system progression on first-line pertuzumab and trastuzumab treatment for HER2-positive metastatic breast cancer in a real-life cohort